US Stock MarketDetailed Quotes

TLPH Talphera

Watchlist
  • 1.030
  • -0.010-0.96%
Close May 24 16:00 ET
17.50MMarket Cap-1471P/E (TTM)

About Talphera Company

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Company Profile

SymbolTLPH
Company NameTalphera
Listing DateFeb 11, 2011
Founded2005
CEOMr. Vincent J. Angotti
MarketNASDAQ
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1850 Gateway Drive,Suite 175
CitySan Mateo
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-216-3500
Websitehttp://www.acelrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Vincent J. Angotti
  • Director and Chief Executive Officer
  • 1.21M
  • Raffi Asadorian
  • Chief Financial Officer and Principal Accounting Officer
  • 742.61K
  • Dr. Pamela P. Palmer, M.D.,PhD
  • Chief Medical Officer
  • 814.27K
  • Badri Dasu
  • Chief Engineering Officer
  • --
  • Adrian Adams
  • Chairman of the Board
  • 104.79K
  • Abhinav Jain
  • Director
  • --
  • Mark A. Wan
  • Independent Director
  • 69.79K
  • Dr. Stephen J. Hoffman,M.D.,PhD
  • Independent Director
  • 47.29K
  • Marina Bozilenko
  • Independent Director
  • 62.29K
  • Jill M. Broadfoot
  • Independent Director
  • 62.29K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg